Plasma is the liquid part of your blood, more than half of it by volume. It carries every cell, nutrient, hormone and antibody your body needs. It is also the raw material for medicines that can only be made from donated human plasma.
If you spin a tube of blood in a centrifuge, it separates into layers: golden plasma on top, a thin pale band of white cells and platelets, and dense red cells at the bottom. Choose a component to see what it does and how medicine uses it.
Plasma is a straw-yellow liquid. Around 92% of it is water. Most of the rest is proteins, and each protein does a specific job in the body. Those proteins are what plasma medicines are made from.
The most abundant plasma protein. It keeps fluid inside the blood vessels and carries hormones, vitamins, fatty acids and drugs around the body.
BecomesAlbumin solutions used for shock, burns, major surgery and liver disease
Antibodies, the body's defense against infection. Plasma pooled from many donors contains a wide range of them.
BecomesImmunoglobulin (IVIG, SCIG) for immune deficiencies and some neurological and autoimmune conditions
Proteins that work together to form a clot. Fibrinogen turns into a fibrin mesh that seals a wound.
BecomesFactor VIII, factor IX, von Willebrand factor, fibrinogen and fibrin sealants
Proteins found in small amounts, such as alpha-1 antitrypsin, which protects the lungs, and C1 esterase inhibitor, which controls swelling.
BecomesTreatments for alpha-1 antitrypsin deficiency and hereditary angioedema
Plasma medicines are not made from chemicals in a lab. Each one starts with a person in a donor chair. Follow the six stages below, each shown step by step.
Timeline is approximate and not to scale. It varies by product and manufacturer.
Plasma is used in two ways. Hospitals transfuse it directly to replace volume and clotting factors in bleeding, trauma and burns. Far more of it is fractionated into concentrated medicines, many of them for rare, chronic conditions.
| Medicine | Made from | Used for |
|---|---|---|
| Immunoglobulin | Antibodies | Primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), Kawasaki disease, immune thrombocytopenia (ITP) and other immune and neurological conditions |
| Albumin | Albumin | Shock, severe burns, major surgery, liver disease and restoring blood volume |
| Clotting factors | Factor VIII, factor IX, von Willebrand factor, fibrinogen | Hemophilia A and B, von Willebrand disease, other bleeding disorders and surgical bleeding |
| Alpha-1 proteinase inhibitor | Alpha-1 antitrypsin | Alpha-1 antitrypsin deficiency, a genetic condition that damages the lungs and liver |
| C1 esterase inhibitor | C1-INH | Hereditary angioedema, which causes sudden swelling that can block the airway |
| Hyperimmune globulins | Specific antibodies | Exposure to rabies, tetanus and hepatitis B, and preventing Rh disease in newborns |
| Transfusion plasma | Whole plasma | Trauma, burns, shock and bleeding where the patient needs volume and clotting factors right away |
= 1 donationOne visit to a plasma center, typically one to three hours, giving roughly 0.8 liters of plasma.
Choose a condition to see how many donations it takes to treat one patient for one year.
Approximate. Assumes about 0.8 L per donation and the U.S. maximum of about 104 donations per donor per year.
The hemophilia figure applies to treatment with plasma-made factor VIII. Many patients now use lab-made options (see the questions below).
People who depend on plasma medicines live in every country, but the plasma comes from very few places. Here is where it is collected, where it falls short and how it moves.
of the world's plasma for medicines is collected in North America, almost all of it in the U.S.
of the immunoglobulin used in the EU is imported from the U.S.
of immunoglobulin a year: the shortfall in Latin America, and again in the Middle East & Africa.
A disruption in one place can be felt by patients everywhere. One reason for the concentration: U.S. rules allow donors to give up to twice a week, while many countries allow far fewer donations a year. That is why more countries are now building plasma collection of their own.
United Plasma helps governments, collectors, manufacturers and the companies that supply them build plasma systems that collect more plasma, efficiently and compliantly. That ranges from national plasma strategy to the day-to-day running of a donation center, built to FDA, EMA, MHRA and MHLW standards.
Straight answers to the questions we hear most, from first-time donors to health ministries.